DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients?

Rezultati

Naziv:	DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients?
Autori:	Šmelcerović, Andrija ; Kocic, Gordana ; Gajic, Mihajlo; Tomović, Katarina ; Djordjevic, Vukica ; Stankovic-Djordjevic, Dobrila ; Anderluh, Marko
Godina:	2020
Publikacija:	FRONTIERS IN PHARMACOLOGY
ISSN:	1663-9812 Frontiers in Pharmacology Pretraži identifikator
Tip rezultata:	Naučni članak
Kolacija:	vol. 11
DOI:	10.3389/fphar.2020.01185
WoS-ID:	000563469100001
Scopus-ID:	2-s2.0-85089837450
PMID:	32848788
PMCID:	PMC7419672
URI:	https://enauka.gov.rs/handle/123456789/412593
Projekat:	Ministry of Education, Science and Technological Development of the Republic of Serbia Serbian Academy of Sciences and Arts, branch in Nis [06-17] Faculty of Medicine of the University of Nis [40] Slovenian Research Agency - Sl
Izvor metapodataka:	Migracija
M-kategorija:	21aM21a - Vodeći međunarodni časopis kategorije M21a

19
SCOPUS^TM

15
PubMed Central^TM

12
OpenCitations

19
WEB OF SCIENCE^TM

Alt metrika

Dimensions

Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.